The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

The Tencent-backed game publisher priced its shares at the top of their range in an offering set to take place on August 10 that will value it at $21.2bn.

Alphabet and Roc Nation-backed share and crypto trading platform developer RobinHood floated at the bottom of its range but still raised almost $2.1bn.

Carnegie Mellon-linked Duolingo raised $521m in an upsized offering and saw its shares rise 36% on their first day.

CapitalG sold $36.3m of shares in an upsized offering for the language learning app developer, which saw its shares rise 36% on their first day.

Icahn School of Medicine spinout Sema4 has completed a reverse merger with CM Life Sciences to begin trading on the Nasdaq Global Select Market.

Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva

The Gruner + Jahr and Susquehanna International Group-backed content recommendation engine developer floated below its range but is slightly up from its IPO price.